/
CHB
$6.64-$0.03 (-0.38%)prev close
Change$-10.03
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Asset Management
Global X China Biotech Innovation ETF
This fund commits at least 80% of its overall assets, alongside any borrowed capital used for investment, to the securities tracked by its benchmark index. This also includes American and Global Depositary Receipts that are derived from those same index securities. The underlying index itself is specifically designed to provide investors with exposure to exchange-listed companies operating directly within China's biotechnology sector. Notably, this fund operates on a non-diversified basis.
- IPO / List date
- Sep 25, 2020
- HQ
- US
Held by traders on TradeandTell
No one on the platform currently holds CHB.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in CHB as of their last filing.
Insider activity (SEC Form 4)
Dividend history
TTM yield · 0.03% ($0.00/share)
| Ex-date | Per share | Pay date |
|---|---|---|
| 2023-12-28 | $0.0019 | 2024-01-08 |
Recent trades on TradeandTell
No one on the platform has traded CHB yet.
